This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Baum, M. A clinical trial of mithramycin in the treatment of advanced malignant disease. Br J Cancer 22, 176–183 (1968). https://doi.org/10.1038/bjc.1968.25
Issue date:
DOI: https://doi.org/10.1038/bjc.1968.25
This article is cited by
-
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype
Cell Death & Disease (2021)
-
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma
Laboratory Investigation (2019)
-
Treatment of malignancy-associated hypercalcemia with 1-hydroxyethylidene diphosphonate (EHDP) or actinomycin D
Journal of Bone and Mineral Metabolism (1988)